Background: Whether proximal gastrectomy (PG) can be applied to patients with proximal advanced gastric cancer (AGC) remains controversial. We aimed to explore the oncological safety of PG for proximal AGC in this study.
Methods: 452 patients undergoing surgery for proximal AGC in the Affiliated Cancer Hospital of Nanjing Medical University were enrolled in this study. 329 patients with AGC were finally analyzed, of which 254 patients underwent total gastrectomy (TG) and 75 patients underwent PG. We used propensity score-matched (PSM) analysis to reduce biases.
Results: After PSM, 67 patients with proximal AGC were included in the PG group and TG group, respectively. The estimated 5-year OS rates for TG and PG group after PSM were 64.3% and 74.9%, respectively, and no significant difference in OS existed between the two groups (p = 0.275). Multivariate analysis showed that PG was not an independent prognostic factor. Incidence of metastasis in No.5 or 6 lymph node (LN) station was significantly higher in the patients with pathological T4 and Borrmann III tumors (9.9% and 10.6%) than those with pathological T2/3 and Borrmann I/II tumors (2.2% and 3.3%). No metastasis was observed in No.5 or 6 LN station in patients with pathological T2/3 tumors or Borrmann I/II tumors when tumor size was ≤4 cm.
Conclusions: PG is a reasonable choice for patients with selected proximal AGC, especially for those with tumors of size ≤4 cm, Borrmann type I/II, and pathological T2/3. Future prospective randomized trials should be conducted first in patients with these specific proximal tumors.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.asjsur.2021.09.029 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Uterus didelphys and cervical cancer: A case report.
Gynecol Oncol Rep
October 2024
Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center, European Metropolitan Area Erlangen-Nuremberg (CCC ER-EMN), Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
Article Synopsis
- Deficiencies in the merging of paramesonephric ducts during embryonic development can lead to Müllerian malformations, which affect reproductive organs and can complicate cancer treatment.
- A 41-year-old woman with atypical Pap smear results and HPV positivity was found to have cervical intraepithelial neoplasia and concurrent uterine and kidney anomalies, which complicated her diagnosis and treatment.
- The case highlights the importance of personalized treatment plans for gynecological cancers in patients with anatomical anomalies, successfully showing that guideline-compliant therapy can be implemented for early-stage cervical cancer despite these challenges.
1657 Resected Gastric Adenocarcinomas at a Single Institution: Outcomes and Trends over 17 Years.
Ann Surg Oncol
October 2024
Department of GI and HPB Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Dr. Ernest Borges Road, Parel, Mumbai, India.
Background: Outside of clinical trials, real-world data of advanced gastric cancers (AGCs) managed with perioperative or adjuvant chemotherapy with a backbone of D2 lymphadenectomy is limited.
Patients And Methods: Curative resections for gastric adenocarcinoma between January 2003 and January 2020 at the Tata Memorial Centre were analyzed, comparing three time periods marking major increments in annual gastric resections (GRs).
Results: 1657 radical gastric resections were performed with a morbidity and mortality rate of 34.
Multivariate prognostic index and triplet regimen efficacy predictive index in locally advanced and metastatic gastric cancer: pooled analysis from three clinical trials using individual patient data.
Ther Adv Med Oncol
February 2024
Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, P. R. China.
Article Synopsis
- The study aimed to create a prognostic index to help predict overall survival and the effectiveness of chemotherapy regimens for advanced gastric cancer patients treated with specific drug combinations.
- Between 2011 and 2021, data from 679 patients undergoing clinical trials were analyzed to develop this index based on various clinical and hematological factors.
- The resulting FARS index identified key prognostic factors that significantly affect survival rates and validated its effectiveness, alongside the TRIS index, which highlighted specific conditions that improved outcomes with triplet chemotherapy regimens.
Clinical significance of systemic inflammation response index and platelet-lymphocyte ratio in patients with adenocarcinoma of the esophagogastric junction and upper gastric cancer.
Heliyon
February 2024
Department of Gastroenterological Surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, 150081, China.
Background: Tumor immunity plays an important role in assessing the tumor progression. The purpose of this study was to investigate the prognostic value of combined systemic inflammation response index (SIRI) and platelet-lymphocyte ratio (PLR) of gastroesophageal junction cancer (AEG) and upper gastric cancer (UGC) patients.
Methods: In this retrospective study, patients from 2003 to 2014 were divided into training and validation sets.
Long-Term Outcome of Proximal Gastrectomy for Upper-Third Advanced Gastric and Siewert Type II Esophagogastric Junction Cancer Compared With Total Gastrectomy: A Propensity Score-Matched Analysis.
Ann Surg Oncol
May 2024
Department of Surgery and Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
Background: This study aimed to investigate the oncologic long-term safety of proximal gastrectomy for upper-third advanced gastric cancer (AGC) and Siewert type II esophagogastric junction (EGJ) cancer.
Methods: The study enrolled patients who underwent proximal gastrectomy (PG) or total gastrectomy (TG) with standard lymph node (LN) dissection for pathologically proven upper-third AGC and EGJ cancers between January 2007 and December 2018. Propensity score-matching with a 1:1 ratio was performed to reduce the influence of confounding variables such as age, sex, tumor size, T stage, N stage, and tumor-node-metastasis (TNM) stage.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!